bullish

Vivos Therapeutics, Inc. - New Strategic Model & Key Regulatory Milestones Provide Revenue Tailwind

176 Views12 Dec 2024 09:54
Issuer-paid
The company’s Complete Airway Repositioning and/or Expansion (CARE) oral devices are patient preferred over market-leading CPAP
What is covered in the Full Insight:
  • Introduction to Vivos Therapeutics
  • Key FDA Clearances and Product Overview
  • New Business Model and Strategic Alliances
  • Market Opportunities in Pediatric OSA
  • Financial and Market Performance
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 50-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Water Tower Research
Research from Water Tower Research
Water Tower Research
Equity Bottom-UpThematic (Sector/Industry)
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x